168 related articles for article (PubMed ID: 25629575)
1. Correlation of the controlled attenuation parameter with indices of liver steatosis in overweight or obese individuals: a pilot study.
Ferraioli G; Tinelli C; Lissandrin R; Zicchetti M; Faliva M; Perna S; Perani G; Alessandrino F; Calliada F; Rondanelli M; Filice C;
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):305-12. PubMed ID: 25629575
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.
Ferraioli G; Calcaterra V; Lissandrin R; Guazzotti M; Maiocchi L; Tinelli C; De Silvestri A; Regalbuto C; Pelizzo G; Larizza D; Filice C
BMC Gastroenterol; 2017 May; 17(1):61. PubMed ID: 28472948
[TBL] [Abstract][Full Text] [Related]
3. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.
de Lédinghen V; Vergniol J; Capdepont M; Chermak F; Hiriart JB; Cassinotto C; Merrouche W; Foucher J; Brigitte le B
J Hepatol; 2014 May; 60(5):1026-31. PubMed ID: 24378529
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
5. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
[TBL] [Abstract][Full Text] [Related]
6. Relationship between indices of obesity obtained by anthropometry and dual-energy X-ray absorptiometry: The Fourth and Fifth Korea National Health and Nutrition Examination Survey (KNHANES IV and V, 2008-2011).
Kim SG; Ko Kd; Hwang IC; Suh HS; Kay S; Caterson I; Kim KK
Obes Res Clin Pract; 2015; 9(5):487-98. PubMed ID: 25484303
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter.
Kaya E; Demir D; Alahdab YO; Yilmaz Y
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1264-7. PubMed ID: 27482784
[TBL] [Abstract][Full Text] [Related]
8. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Chan WK; Nik Mustapha NR; Mahadeva S
J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
[TBL] [Abstract][Full Text] [Related]
9. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography.
Yilmaz Y; Ergelen R; Akin H; Imeryuz N
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1330-4. PubMed ID: 23660937
[TBL] [Abstract][Full Text] [Related]
11. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
[TBL] [Abstract][Full Text] [Related]
12. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
[TBL] [Abstract][Full Text] [Related]
13. Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.
Shin J; Kim MJ; Shin HJ; Yoon H; Kim S; Koh H; Lee MJ
BMC Pediatr; 2019 Apr; 19(1):112. PubMed ID: 30987634
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
[TBL] [Abstract][Full Text] [Related]
15. Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults.
Price JC; Dodge JL; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski S; Tien PC
AIDS; 2017 Sep; 31(15):2119-2125. PubMed ID: 28723710
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant.
Hong YM; Yoon KT; Cho M; Chu CW; Rhu JH; Yang KH; Lee JW
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):805-810. PubMed ID: 28379854
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of the controlled attenuation parameter for detecting liver steatosis in health checkup examinees.
Kim JK; Lee KS; Choi JR; Chung HJ; Jung DH; Lee KA; Lee JI
Gut Liver; 2015 May; 9(3):405-10. PubMed ID: 25717046
[TBL] [Abstract][Full Text] [Related]
18. MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings.
Pozzato C; Radaelli G; Dall'Asta C; Verduci E; Villa A; Villa C; Scaglioni S; Riva E; Pontiroli AE; Cornalba G; Giovannini M
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):493-9. PubMed ID: 18852643
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study.
Sulyok M; Makara M; Rupnik Z; Ferenci T; Újhelyi E; Kormos L; Gerlei Z; Szlávik J; Horváth G; Vályi-Nagy I
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):679-85. PubMed ID: 25923943
[TBL] [Abstract][Full Text] [Related]
20. Obesity-Induced Hepatic Steatosis Is Partly Mediated by Visceral Fat Accumulation in Subjects with Overweight/Obesity: A Cross-Sectional Study.
Liu F; Chen S; Li X; Li S; Xiao Y; Han J; Tu Y; Bao Y; Bai W; Yu H
Obes Facts; 2023; 16(2):164-172. PubMed ID: 36257286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
